Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador
Background: Complications of COVID-19 can include neurological, psychiatric, psychological, and psychosocial sequelae. Little is known about the consequences of COVID-19 on the cognitive functions of patients in the subacute phase of the disease. Objective: The objective of the study was to determin...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Permanyer
2022-10-01
|
| Series: | Revista Mexicana de Neurociencia |
| Subjects: | |
| Online Access: | https://www.revmexneurociencia.com/frame_esp.php?id=185 |
| _version_ | 1818508993747746816 |
|---|---|
| author | Alejandro Checa Eliana Navas Verónica Valencia Jessica Alcívar |
| author_facet | Alejandro Checa Eliana Navas Verónica Valencia Jessica Alcívar |
| author_sort | Alejandro Checa |
| collection | DOAJ |
| description | Background: Complications of COVID-19 can include neurological, psychiatric, psychological, and psychosocial sequelae. Little is known about the consequences of COVID-19 on the cognitive functions of patients in the subacute phase of the disease. Objective: The objective of the study was to determine if there is an incidence of cognitive impairment in patients with COVID-19 with mild to moderate symptoms in the remission phase. Method: This is a cross-sectional study conducted between April 2021 and August 2021 at the Eugenio Espejo Hospital in Quito, Ecuador. The Montreal Cognitive Assessment test was applied to COVID-19 patients with mild to moderate symptoms. Results: A total of 50 subjects were recruited, 88% (n = 44) presented cognitive deterioration and only 12% (n = 6) showed a normal score. Conclusions: In our cohort study, patients with COVID-19 with mild-moderate symptoms are at high risk of cognitive impairment.
|
| first_indexed | 2024-12-10T22:39:28Z |
| format | Article |
| id | doaj.art-4ccf3cf47b60414ba809f6500181b121 |
| institution | Directory Open Access Journal |
| issn | 2604-6180 |
| language | English |
| last_indexed | 2024-12-10T22:39:28Z |
| publishDate | 2022-10-01 |
| publisher | Permanyer |
| record_format | Article |
| series | Revista Mexicana de Neurociencia |
| spelling | doaj.art-4ccf3cf47b60414ba809f6500181b1212022-12-22T01:30:45ZengPermanyerRevista Mexicana de Neurociencia2604-61802022-10-0123410.24875/RMN.21000060Cognitive impairment in people with COVID-19 with mild-moderate symptoms in EcuadorAlejandro Checa0Eliana Navas1Verónica Valencia2Jessica Alcívar3Mental Health Unite, Hospital de Especialidades Eugenio Espejo, Quito, EcuadorMental Health Unite, Hospital de Especialidades Eugenio Espejo, Quito, EcuadorMental Health Unite, Hospital de Especialidades Eugenio Espejo, Quito, EcuadorMental Health Unite, Hospital de Especialidades Eugenio Espejo, Quito, EcuadorBackground: Complications of COVID-19 can include neurological, psychiatric, psychological, and psychosocial sequelae. Little is known about the consequences of COVID-19 on the cognitive functions of patients in the subacute phase of the disease. Objective: The objective of the study was to determine if there is an incidence of cognitive impairment in patients with COVID-19 with mild to moderate symptoms in the remission phase. Method: This is a cross-sectional study conducted between April 2021 and August 2021 at the Eugenio Espejo Hospital in Quito, Ecuador. The Montreal Cognitive Assessment test was applied to COVID-19 patients with mild to moderate symptoms. Results: A total of 50 subjects were recruited, 88% (n = 44) presented cognitive deterioration and only 12% (n = 6) showed a normal score. Conclusions: In our cohort study, patients with COVID-19 with mild-moderate symptoms are at high risk of cognitive impairment. https://www.revmexneurociencia.com/frame_esp.php?id=185COVID-19. Cognitive impairment. Mild to moderate. |
| spellingShingle | Alejandro Checa Eliana Navas Verónica Valencia Jessica Alcívar Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador Revista Mexicana de Neurociencia COVID-19. Cognitive impairment. Mild to moderate. |
| title | Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador |
| title_full | Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador |
| title_fullStr | Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador |
| title_full_unstemmed | Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador |
| title_short | Cognitive impairment in people with COVID-19 with mild-moderate symptoms in Ecuador |
| title_sort | cognitive impairment in people with covid 19 with mild moderate symptoms in ecuador |
| topic | COVID-19. Cognitive impairment. Mild to moderate. |
| url | https://www.revmexneurociencia.com/frame_esp.php?id=185 |
| work_keys_str_mv | AT alejandrocheca cognitiveimpairmentinpeoplewithcovid19withmildmoderatesymptomsinecuador AT eliananavas cognitiveimpairmentinpeoplewithcovid19withmildmoderatesymptomsinecuador AT veronicavalencia cognitiveimpairmentinpeoplewithcovid19withmildmoderatesymptomsinecuador AT jessicaalcivar cognitiveimpairmentinpeoplewithcovid19withmildmoderatesymptomsinecuador |